66
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Determining the optimal cutoff point for lymph node density and its impact on overall survival in children with Wilms’ tumor

, , , , &
Pages 759-766 | Published online: 15 Jan 2019

References

  • DavidoffAMWilms’ tumorCurr Opin Pediatr200921335736419417665
  • FriedmanADWilms tumorPediatr Rev2013347328330 discussion 33023818087
  • CottonCAPetersonSNorkoolPATakashimaJGrigorievYBreslowNEEarly and late mortality after diagnosis of Wilms tumorJ Clin Oncol20092781304130919139431
  • YouHYangJLiuQThe impact of the lymph node density on overall survival in patients with Wilms’ tumor: a SEER analysisCancer Manag Res20181067167729670401
  • SaltzmanAFCarrascoAJrAminiAPatterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: an analysis of the National cancer databaseJ Pediatr Urol2018142161.e1161.e829133167
  • CampRLDolled-FilhartMRimmDLX-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimizationClin Cancer Res200410217252725915534099
  • LiSQJiangYHLinJAlbumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individualsCancer Med2018741221123129533009
  • ChenXDengYShiYLoss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancerOncol Lett20181545043505529545901
  • PanCWangXChenWReevaluation of glypican-3 as a prognostic marker in HCC using X-tile softwareMed Oncol201532135925432695
  • The Comprehensive R Archive NetworkAn introduction to recursive partitioning using the RPART Routines2018 Available from: http://cran.r-project.org/web/packages/rpart/vignettes/longintro.pdfAccessed February 23, 2018
  • RauCSWuSCChienPCPrediction of mortality in patients with isolated traumatic subarachnoid hemorrhage using a decision tree classifier: a retrospective analysis based on a trauma registry systemInt J Environ Res Public Health20171411E142029165330
  • DialloJSAldejmahAMouhimAFNoxa and Puma expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree modelClin Cancer Res200713237044705218056181
  • HeagertyPJLumleyTPepeMSTime-dependent ROC curves for censored survival data and a diagnostic markerBiometrics200056233734410877287
  • YoudenWJIndex for rating diagnostic testsCancer195031323515405679
  • ToyokawaTKuboNTamuraTThe pretreatment controlling nutritional status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective studyBMC Cancer201616172227599460
  • LePHLinWRKuoCJClinical characteristics of cytomegalovirus colitis: a 15-year experience from a tertiary reference centerTher Clin Risk Manag2017131585159329290686
  • DuchesneJCTatumDJonesGMulti-institutional analysis of neutrophil-to-lymphocyte ratio (NLR) in patients with severe hemorrhage: a new mortality predictor valueJ Trauma Acute Care Surg201783588889328837540
  • Surveillance, Epidemiology, and End Results (SEER) ProgramSEER*Stat database: incidence–SEER 18 Regs research data+Hurricane Katrina impacted Louisiana cases, Nov 2016 Sub (1973–2014)–linked to county attributes–Total U.S., 1969–2015 counties. National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2017 based on the November 2016 submission Available from: http://www.seer.cancer.govAccessed February 28, 2018
  • D’AngioGJEvansABreslowNThe treatment of Wilms’ tumor: results of the Second National Wilms’ tumor StudyCancer1981479230223116164480
  • D’AngioGJBreslowNBeckwithJBTreatment of Wilms’ tumor. Results of the third National Wilms’ tumor StudyCancer19896423493602544249
  • GreenDMBreslowNEBeckwithJBComparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms’ tumor: a report from the National Wilms’ tumor Study GroupJ Clin Oncol19981612372459440748
  • GreenDMBreslowNEBeckwithJBTreatment with nephrectomy only for small, stage I/favorable histology Wilms’ tumor: a report from the National Wilms’ tumor Study GroupJ Clin Oncol200119173719372411533093
  • XuYFYiYQiuSJPEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infectionJ Hepatol2011535872879
  • ZhangJXSongWChenZHPrognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysisLancet Oncol201314131295130624239208
  • BreimanLFriedmanJHOlshenRAStoneCJClassification and Regression TreesNew YorkChapman & Hall/CRC1984
  • CiampiAThiffaultJNakacheJPAsselainBStratification by stepwise regression, correspondence analysis and recursive partition: a comparison of three methods of analysis for survival data with covariatesComput Stat Data Anal198643185204
  • SegalMRRegression trees for censored dataBiometrics19884413537
  • MaXZengHZhangJChenLJiaHNew practical methods to obtain crucial data in performing diagnostic meta-analysis of the published literatureJ Evid Based Med2018111566329380525
  • PerkinsNJSchistermanEFThe inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curveAm J Epidemiol2006163767067516410346
  • MetzgerMLDomeJSCurrent therapy for Wilms’ tumorOncologist2005101081582616314292
  • VujanićGMSandstedtBHarmsDSIOP Nephroblastoma Scientific CommitteeRevised International Society of Paediatric Oncology (SIOP) Working classification of renal tumors of childhoodMed Pediatr Oncol2002382798211813170
  • KalapurakalJADomeJSPerlmanEJManagement of Wilms’ tumour: current practice and future goalsLancet Oncol200451374614700607
  • National Cancer Institute [homepage on the Internet]Surveillance, epidemiology and end results (SEER) program2018 Available from: http://www.seer.cancer.govAccessed February 28, 2018
  • BreslowNOlshanABeckwithJBGreenDMEpidemiology of Wilms tumorMed Pediatr Oncol19932131721817680412
  • MitryECiccolalloLColemanMPGattaGPritchard-JonesKEUROCARE Working GroupIncidence of and survival from Wilms’ tumour in adults in Europe: data from the EUROCARE studyEur J Cancer200642142363236816891111
  • TerenzianiMSpreaficoFColliniPAdult Wilms’ tumor: a monoinstitutional experience and a review of the literatureCancer2004101228929315241825
  • AliANDiazRShuHKPaulinoACEsiashviliNA surveillance, epidemiology and end results (SEER) program comparison of adult and pediatric Wilms’ tumorCancer201211892541255121918969